SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-20-001679
Filing Date
2020-03-31
Accepted
2020-03-31 16:35:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 OXFORD IMMUNOTEC GLOBAL PLC p20-0848sc13g.htm SC 13G 62396
  Complete submission text file 0000902664-20-001679.txt   64145
Mailing Address 540 MADISON AVENUE 32ND FLOOR NEW YORK NY 10022
Business Address 540 MADISON AVENUE 32ND FLOOR NEW YORK NY 10022 514-281-8082
Senvest Management, LLC (Filed by) CIK: 0001328785 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ
Business Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ 44 01235 442780
Oxford Immunotec Global PLC (Subject) CIK: 0001586049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87926 | Film No.: 20762210
SIC: 2835 In Vitro & In Vivo Diagnostic Substances